ARDA Software for the Detection of mtmDR

Exclusion Criteria

• •1. Self-reported visual symptoms and persistent blurred vision (greater than 24 hours); including vision loss that cannot be corrected (e.g. with eye glasses).
• •2. Diagnosed with macular edema, any known retinopathy, radiation retinopathy, or retinal vein occlusion.
• •3. History of laser treatment of the retina or injections into either eye, or any history of retinal surgery.
• •4. Scheduled to undergo the following surgeries before completion of the study imaging: cataract surgery (including any related follow-up procedures) or vitrectomy.
• •5. Currently participating in an interventional study.
• •6. Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia or previous enucleation, etc.).
• •7. Participant is contraindicated for imaging by fundus imaging system used in the study; e.g.
• •1. Participant is hypersensitive to light (side effect of medication or due to unknown etiology)
• •2. Participant has undergone photodynamic therapy (PDT)
• •3. Previous issues with dilation (angle closure, inability to dilate, allergy to dilation drops).
• •8. Known pregnancy or possibility of pregnancy